Marseilles, France

Ariane Morel


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Ariane Morel: Innovator in Cancer Treatment

Introduction

Ariane Morel is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for cancer and infectious diseases. With a total of seven patents to her name, Morel is recognized for her groundbreaking work in redirecting natural killer (NK) cells to target specific cells of interest.

Latest Patents

Among her latest patents is the "Multispecific NK engager protein." This invention provides multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest without causing non-specific activation of NK cells in the absence of target cells. This technology holds promise for treating diseases, notably cancer and infectious diseases. Another significant patent is related to "Variable regions for NKp46 binding proteins." This patent includes NKp46-binding immunoglobulin variable regions and proteins such as antibodies and multispecific proteins that can bind and specifically redirect NK cells to lyse a target cell of interest, further emphasizing their utility in disease treatment.

Career Highlights

Ariane Morel is currently associated with Innate Pharma, a company dedicated to developing innovative immunotherapies for cancer treatment. Her work at Innate Pharma has positioned her as a key player in the biotechnology sector, contributing to advancements that could change the landscape of cancer therapy.

Collaborations

Throughout her career, Morel has collaborated with notable colleagues, including Laurent Gauthier and Nadia Anceriz. These collaborations have fostered a dynamic environment for innovation and research, enhancing the potential impact of their collective work.

Conclusion

Ariane Morel's contributions to biotechnology and her innovative patents reflect her commitment to advancing cancer treatment. Her work continues to inspire and pave the way for future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…